Lv2
130 积分 2024-03-22 加入
19P Mortality among EGFR-mutated advanced NSCLC patients after frontline osimertinib treatment: A real-world, US attrition analysis
13天前
已完结
Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer
13天前
已完结
Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort Multicenter Interventional Study of Osimertinib with or Without Savolitinib in De Novo MET Aberrant, EGFR-Mutant Patients with Advanced Non-Small-Cell Lung Cancer: The FLOWERS Trial
16天前
已完结
Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
23天前
已完结
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
25天前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
1个月前
已完结
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
1个月前
已完结
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
1个月前
已完结
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
2个月前
已完结
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes
2个月前
已完结
维生素D与血压控制的相关性
3个月前
已采纳
外周Aβ和系统疾病在阿尔茨海默病发生中的作用及机制研究
3个月前
已采纳
多孔和中空微球的制备及其在光固化涂料中隔热性能研究
3个月前
已采纳
太极拳运动对老年2型糖尿病患者的干预作用
4个月前
已采纳
恶性黑色素瘤的规范化治疗-《中国黑色素瘤诊断治疗共识》解读
4个月前
已采纳
伏立康唑在肾移植患者中的群体药动学研究
4个月前
已采纳
感冒咳嗽颗粒高效液相色谱指纹图谱
4个月前
已采纳
阿立哌唑原料多晶型分析及其质量标准提高研究
4个月前
已采纳
皖公网安备34019202002308
